Ocular involvement in connective tissue disorders

Current Allergy and Asthma Reports

Volumn 5, Issue 4, 2005, Pages 323-326

  Young, Stephanie ^a  

^a ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CYCLOSPORIN A; EYE DROPS; HYDROXYCHLOROQUINE; INTERCELLULAR ADHESION MOLECULE 1; LUBRICATING AGENT; MUCOLYTIC AGENT;

CHOROID DISEASE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; EYE DISEASE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; KERATITIS; KERATOCONJUNCTIVITIS SICCA; OPTIC NERVE DISEASE; POLYMYOSITIS; PSORIATIC ARTHRITIS; RETINA MACULOPATHY; RETINA VASCULITIS; REVIEW; RHEUMATOID ARTHRITIS; SCLERITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UVEITIS; VISUAL ACUITY;

EID: 23844480664     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-005-0076-y     Document Type: Review

References (33)

1. Pepose JS, Akata RF, Pflugfelder SC, et al.: Mononuclear cell phenotypes and immunoglobulin gene rearrangement in lacrimal gland biopsies from patients with Sjogren's syndrome. Ophthalmol 1990, 97:1599-1602.
2. Fox RI: Sjogren's syndrome: evolving therapies. Expert Opin Investig Drugs 2003, 12:247-254.
3. Frith P, Burge SM, Millard PR, Wojnarowska F: External ocular findings in lupus erythematosus: a clinical and immunohistopathological study. Br J Ophthalmol 1990, 74:163-167.
4. Noble BA, Loh RS, Maclennan S, et al.: Comparison of autologous serum eyedrops with conventional therapy in a random controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004, 88:647-652.
5. Gao J, Morgan G, Tieu D, et al.: ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjogren's syndrome-like MRL/lpr mice. Exp Eye Res 2004, 78:823-835.
6. Messmer EM, Foster CS: Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999, 43:379-396.
7. Squirrell DM, Winfield J, Amos RS: Peripheral ulcerative keratitis "corneal melt" and rheumatoid arthritis: a case series. Rheumatology (Oxford) 1999, 38:1245-1248.
8. Perez VL, Azar DT, Foster CS: Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol 2002, 17:124-130.
9. Sainz de la Maza M, Foster CS, Jabbur NS: Scleritis associated with systemic diseases. Ophthalmol 1995, 102:687-692.
10. Sainz de la Maza M, Foster CS, Jabbur NS: Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmol 1994, 101:1281-1286.
11. Nguyen QD, Foster CS: Scleral patch grafting in the management of necrotizing scleritis. Int Ophthalmol Clin 1991, 39:109-131.
12. Edelston C, Reddy MA, Stanford MR, Graham EM: Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol 2003, 135:676-680.
13. Tugal-Tutkun I, Havrilikova Y, Power WJ, Foster CS: Changing patterns in uveitis in childhood. Ophthalmol 1996, 103:375-383.
14. Holland GN, Stiehm ER: Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol 2003, 135:867-878.
15. Foster CS: Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 2003, 14:395-398.
16. Pato E, Banares A, Jover, et al.: Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. J Rheumatol 2000, 27:2198-2202.
17. Anderson NG, Garcia-Valenzuela E, Martin DF: Hypopyon uveitis and relapsing polychondritis: a report of 2 patients and review of autoimmune hypopyon uveitis. Ophthalmology 2004, 111:1251-1254.
18. Martin TM, Smith JR, Rosenbaum JT: Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies. Curr Opin Rheumatol 2002, 14:337-341.
19. Martin TM, Rosenbaum JT: Identifying genes that cause disease: HLA-B27, the paradigm, the promise, the perplexity. Br J Ophthalmol 1998, 82:1354-1355.
20. Montehermoso A, Cervera R, Font J, et al.: Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum 1999, 28:326-332.
21. Snyers B, Lambert M, Hardy JP: Retinal and choroidal vaso-occlusive disease in SLE associated with antiphospholipid antibodies. Retina 1990, 10:255-259.
22. Jabs DA, Fine SL, Hochberg MC, et al.: Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol 1986, 104:558-563.
23. Nguyen QD, Uy HS, Akpek EK, et al.: Choroidopathy of systemic lupus erythematosus. Lupus 2000, 9:288-298.
24. Jabs DA, Hanneken AM, Schachat AD, et al.: Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol 1998, 106:230-234.
25. Matsuo T, Nakayama T, Koyanani T, Matsuo U: Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica 1987, 195:97-99.
26. Kinyoun JL, Kalina RE: Visual loss from choroidal ischemia. Am J Ophthalmol 1986, 101:650-656.
27. Aronson AJ, Ordonez NG, Diddie KR, Ernest JT: Immune-complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med 1979, 139:1312-1313.
28. Au A, O'Day J: Review of the vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Exper Ophthalmol 2004, 32:87-100.
29. Cunningham ET, Alfred PR, Irvine AR: Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmol 1996, 103:2081-2090.
30. Khng CGYW, Yap EY, Au-Eong KG, et al.: Central serous chorioretinopathy complicating systemic lupus erythematosus: a case series. Clin Exper Ophthalmol 2000, 28:309-313.
31. Cambiaggi A: Unusual ocular lesions in a case of systemic lupus erythematosus. AMA Arch Ophthalmol 1957, 57:451-453.
32. Jabs DA, Miller NR, Newman SA, et al.: Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986, 104:546-564.
33. Giorgi D, Balacco Gabrieli C: Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis and a review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin Rheumatol 1999, 18:124-131.